emashworth
Contributor
Hey Everyone
I am preparing for my CPC exam, and I have a question about a Problem in the 2012 Step-By-Step Medical Coding Textbook:
A patient is admitted with uncontrolled nausea and vomiting after chemotherapy treatment for lung cancer.
A. How many codes would be needed to accurately report this case?__ ( plus an E code)
B. What is the first listed diagnosis?__
C. What is the secondary diagnosis?__
D. What is the code for the first listed diagnosis?__
E. What is the code for the secondary diagnosis and the E code?__, __
according to the answer key the correct answers are as follows:
A. Two
B. Uncontrolled nausea and vomiting
C. Lung cancer
D. 787.01 (nausea and vomiting)
E. 162.9 ( neoplasm, lung, primary) E933.1 ( Tables of Drugs and Chemicals, Antineoplastic Agents, Theraputic Use)
My question is if you should assign assign V58.11( Encounter for antineoplastic therapy) as the primary, followed by 787.01, 162.9, E933.1
That is the impression that I got when reviewing the chapter guidelines for neopolasms, section E-3.
Any insight would be much appreciated!
I am preparing for my CPC exam, and I have a question about a Problem in the 2012 Step-By-Step Medical Coding Textbook:
A patient is admitted with uncontrolled nausea and vomiting after chemotherapy treatment for lung cancer.
A. How many codes would be needed to accurately report this case?__ ( plus an E code)
B. What is the first listed diagnosis?__
C. What is the secondary diagnosis?__
D. What is the code for the first listed diagnosis?__
E. What is the code for the secondary diagnosis and the E code?__, __
according to the answer key the correct answers are as follows:
A. Two
B. Uncontrolled nausea and vomiting
C. Lung cancer
D. 787.01 (nausea and vomiting)
E. 162.9 ( neoplasm, lung, primary) E933.1 ( Tables of Drugs and Chemicals, Antineoplastic Agents, Theraputic Use)
My question is if you should assign assign V58.11( Encounter for antineoplastic therapy) as the primary, followed by 787.01, 162.9, E933.1
That is the impression that I got when reviewing the chapter guidelines for neopolasms, section E-3.
Any insight would be much appreciated!